Autonomix Medical's research on treating pancreatic cancer pain has been accepted for presentation at the SIO 2025 Annual Meeting. Autonomix Medical, Inc. has announced that its abstract has been ...
Avita Medical Announces Five RECELL® Abstracts Accepted for Presentation at American Burn Association (ABA) 50th Annual Meeting RECELL to be Prominently Featured at Annual ABA Meeting to be Held in ...
Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to the principle that knowledge conquers cancer. Together with the Association for Clinical Oncology, ASCO ...
SYDNEY, AUSTRALIA, July 28, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, ...
Abivax's late-breaking abstract on its ABX464 phase 2b clinical data in UC has been accepted for this year's UEG Week and will be presented by Prof. Séverine Vermeire, M.D., Ph.D, the principal ...
Multiple abstracts accepted featuring imdusiran clinical data – highlighting progress toward a potential functional cure for chronic hepatitis B virus AB-101 clinical data abstract recognized as a ...
AUSTIN, Texas, April 18, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate for Pediatric Growth Hormone Deficiency (PGHD) ...
CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that six abstracts have been accepted for presentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results